Royalty Pharma plc (Nasdaq: RPRX) today announced that it has entered into an agreement with Biogen to provide research and development (R&D) funding of up ...
Objectives Ethnicity and health outcomes are intrinsically interrelated, although mechanisms are complex. SLE is a disease ...
Biogen has bagged $250 million to advance a key pipeline prospect. | Biogen has bagged $250 million to advance a key pipeline ...
Royalty Pharma to provide R&D investment of up to $250 million for Biogen’s litifilimab, a potential first-in-class biologic in Phase 3 development for the treatment of lupusNEW YORK, Feb. 12, 2025 ...
Researchers at Linköping University in Sweden made an unexpected discovery while investigating genetically unique women.
Background SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene ...
Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.
Distractify on MSN20h
Why Does Seal Have Scars? Details on What Happened to His Face and HairWhy does Seal have scars? The singer's facial scars and bumps are caused by a skin condition. Learn what happened to his face ...
21hon MSN
Researchers at Linköping University in Sweden made an unexpected discovery while investigating genetically unique women.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback